- Condition: Whiplash Injuries
Interventions: Drug: Atomoxetine; Drug: Citalopram
Sponsors: Vrije Universiteit Brussel; Vrije Universiteit Brussel
Not yet recruiting - verified May 2012 - Condition: Treatment-Resistant Depression
Intervention:
Sponsors: Mclean Hospital; Mclean Hospital; Pfizer; Massachusetts General Hospital
Not yet recruiting - verified May 2012 - Condition: Major Depressive Disorder
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; ElMindA Ltd
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Intervention: Drug: Participants will be prescribed an approved selective serotonin re-uptake inhibitor (SSRI) antidepressant.
Sponsors: Baker IDI Heart and Diabetes Institute; Baker IDI Heart and Diabetes Institute; Alfred and Baker Medical Unit - Alfred Hospital; Monash Medical Centre - Southern Health; Ballarat Health Service Psychiatric Services
Not yet recruiting - verified March 2012 - Condition: Obsessive-Compulsive Disorder
Interventions: Drug: N-Acetylcysteine (NAC); Drug: Placebo
Sponsors: University of Sao Paulo; University of Sao Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified March 2012 - Conditions: Major Depressive Disorder (MDD); Coronary Heart Disease (CHD); Cardiovascular Disease (CVD)
Interventions: Drug: Valdoxan (agomelatine); Drug: Lexapro (escitalopram)
Sponsors: Baker IDI Heart and Diabetes Institute; Baker IDI Heart and Diabetes Institute
Not yet recruiting - verified November 2011 - Condition: Perimenopausal Depression
Intervention: Drug: Tibolone
Sponsors: The Alfred; The Alfred
Recruiting - verified January 2012 - Condition: Major Depressive Disorder
Interventions: Drug: SSRI antidepressants; Behavioral: attributional retraining
Sponsors: Nanjing Medical University; Nanjing Medical University
Not yet recruiting - verified October 2011 - Condition: Major Depressive Disorder
Intervention: Drug: LY2216684
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified February 2012 - Condition: Ejaculation
Interventions: Drug: Treatment sequence 2; Drug: Treatment sequence 1
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Recruiting - verified May 2012 - Condition: Treatment Outcome
Interventions: Drug: Lu AA21004; Drug: Escitalopram
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified May 2012 - Condition: Obsessive-compulsive Disorder
Interventions: Drug: Ondansetron; Drug: Placebo
Sponsors: Transcept Pharmaceuticals; Transcept Pharmaceuticals
Recruiting - verified March 2012 - Conditions: Depression; Asthma
Interventions: Drug: Escitalopram; Drug: Placebo
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Major Depressive Disorder (MDD)
Interventions: Drug: LY2216684; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Interventions: Drug: LY2216684; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Intervention: Drug: Creatine
Sponsors: University of Utah; University of Utah
Recruiting - verified October 2011 - Condition: Posttraumatic Stress Disorder
Interventions: Drug: Mirtazapine; Drug: Sertraline; Other: Sugar pill
Sponsors: Research Foundation for Mental Hygiene; Research Foundation for Mental Hygiene; National Institute of Mental Health (NIMH)
Recruiting - verified July 2010 - Condition: Major Depressive Disorder
Interventions: Drug: LY2216684; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Complicated Grief; Bereavement
Interventions: Drug: Citalopram; Behavioral: Complicated Grief Treatment; Other: Placebo
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute of Mental Health (NIMH); American Foundation for Suicide Prevention
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Intervention: Drug: Lisdexamfetamine Dimesylate 20-50 mg
Sponsors: Mclean Hospital; Mclean Hospital; Shire Development LLC
Recruiting - verified March 2012 - Conditions: Heart Failure; Depression
Interventions: Behavioral: Cognitive Behavior Therapy; Other: Heart Failure Self-care Education
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Condition: Obsessive-Compulsive Disorder
Interventions: Drug: pregabalin; Drug: Placebo
Sponsors: McMaster University; Hamilton Health Sciences Corporation; Pfizer
Recruiting - verified August 2010 - Condition: Major Depressive Disorder With Psychotic Features
Interventions: Drug: Quetiapine monotherapy; Drug: Quetiapine with SSRI
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified February 2012 - Conditions: Chronic Kidney Disease; Depression
Interventions: Drug: Sertraline; Drug: placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; University of Texas Southwestern Medical Center
Recruiting - verified May 2012 - Conditions: Mood Disorder; Mental Disorder Diagnosed in Childhood; Attention Deficit and Disruptive Behavior Disorder; Attention Deficit Hyperactivity Disorder
Interventions: Drug: Citalopram; Drug: Methylphenidate
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified July 2011 - Conditions: Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder; Delusional Disorder; Psychotic Disorder
Intervention: Drug: Risperidone/Olanzapine and PET scans
Sponsors: Centre for Addiction and Mental Health; Centre for Addiction and Mental Health
Recruiting - verified April 2012 - Conditions: Breast Cancer; Depression; Hot Flashes; Psychosocial Effects of Cancer and Its Treatment
Interventions: Drug: citalopram hydrobromide; Drug: escitalopram oxalate; Drug: gabapentin; Drug: sertraline hydrochloride; Drug: tamoxifen citrate; Drug: venlafaxine; Genetic: molecular genetic technique; Other: high performance liquid chromatography; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: adjuvant therapy
Sponsors: Mayo Clinic; Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Ziprasidone; Drug: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Vanderbilt University
Recruiting - verified April 2012 - Conditions: Obsessive-compulsive Disorder; Ocd
Interventions: Drug: riluzole; Drug: placebo
Sponsors: Yale University; Yale University
Recruiting - verified January 2012
 |
Join Clinical trials for Selective serotonin reuptake inhibitors |
